May 31, 2021

Ulcerative Colitis

Study title Phase 1, Open Label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in […]
May 31, 2021

Ulcerative Colitis

Study title ECO-RESET: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults with Active Mild-to-Moderate Ulcerative […]
May 31, 2021

Ulcerative Colitis

Study title A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis (QUASAR) Disease or condition Ulcerative colitis Study type Interventional  (Clinical Trial) […]
JOIN NOW